0.766
Geovax Labs Inc stock is traded at $0.766, with a volume of 865.51K.
It is up +2.16% in the last 24 hours and down -6.59% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$0.7498
Open:
$0.7686
24h Volume:
865.51K
Relative Volume:
0.54
Market Cap:
$19.43M
Revenue:
$356.60K
Net Income/Loss:
$-24.32M
P/E Ratio:
-0.0829
EPS:
-9.24
Net Cash Flow:
$-27.24M
1W Performance:
+0.87%
1M Performance:
-6.59%
6M Performance:
-54.13%
1Y Performance:
-89.54%
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GOVX
Geovax Labs Inc
|
0.766 | 18.77M | 356.60K | -24.32M | -27.24M | -9.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
Apr-15-25 | Reiterated | D. Boral Capital | Buy |
Nov-11-24 | Initiated | Alliance Global Partners | Buy |
Jul-16-24 | Initiated | ROTH MKM | Buy |
Nov-19-20 | Initiated | Maxim Group | Buy |
Geovax Labs Inc Stock (GOVX) Latest News
GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock? - sharewise.com
GeoVax Announces Allowance of Patent Protecting Multi-Antigen COVID-19 Vaccine Constructs - Yahoo Finance
Bollinger Band Squeeze Points to Volatility in GeoVax Labs Inc.July 2025 PreEarnings & Weekly High Potential Alerts - mustnews.co.kr
Order Flow Trends Show Accumulation in GeoVax Labs Inc.July 2025 Chart Watch & Reliable Intraday Trade Alerts - thegnnews.com
GeoVax Labs Inc. Equity Warrant Volume Confirms Breakout — Analysts Bullish2025 Dividend Review & AI Forecast for Swing Trade Picks - beatles.ru
GeoVax Labs Stock (GOVX) Opinions on Vaccine Market Developments - Quiver Quantitative
GeoVax to Share Updates on GEO-MVA and Mpox Vaccine at Emerging Growth Conference - citybuzz -
Is GeoVax Labs Inc. forming bullish engulfing patternsJuly 2025 Setups & Weekly Top Gainers Alerts - newsimpact.co.kr
GeoVax to Present at the Emerging Growth Conference on August 20, 2025 - Yahoo Finance
Can GeoVax Labs Inc. Equity Warrant reach resistance levels soonMarket Activity Recap & Short-Term Trading Alerts - thegnnews.com
Can GeoVax Labs Inc. stock double in the next yearWeekly Risk Report & Expert Verified Stock Movement Alerts - thegnnews.com
Options Data Show Bullish Bias in GeoVax Labs Inc. Equity WarrantJuly 2025 Fed Impact & Weekly Market Pulse Updates - classian.co.kr
Is GeoVax Labs Inc. stock undervalued right now2025 Market Outlook & Reliable Entry Point Alerts - mustnews.co.kr
Using AI based signals to follow GeoVax Labs Inc. Equity WarrantJuly 2025 Levels & Safe Capital Investment Plans - Newser
Is GeoVax Labs Inc. stock poised for growthRisk Management & Real-Time Volume Analysis Alerts - Newser
GeoVax Labs Inc. stock trendline breakdownJuly 2025 Review & Weekly High Potential Alerts - Newser
GeoVax Labs Inc. Equity Warrant Approaches Support With Recovery in Sight2025 Stock Rankings & Pattern Based Trade Signal System - 선데이타임즈
Has GeoVax Labs Inc. Equity Warrant formed a bullish divergenceWeekly Trade Summary & Weekly High Return Forecasts - Newser
Will GeoVax Labs Inc. outperform the market2025 Technical Patterns & Smart Investment Allocation Tips - Newser
Why GeoVax Labs Inc. Equity Warrant stock attracts strong analyst attentionMarket Growth Report & Stepwise Trade Signal Implementation - Newser
Can GeoVax Labs Inc. hit a new high this month2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
GeoVax Labs Inc. Equity Warrant recovery potential after sell offEarnings Miss & Weekly High Conviction Trade Ideas - Newser
Does GeoVax Labs Inc. Equity Warrant show high probability of reboundJuly 2025 Patterns & Weekly Top Gainers Trade List - Newser
How GeoVax Labs Inc. Equity Warrant stock performs during market volatilityJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser
What earnings revisions data tells us about GeoVax Labs Inc.July 2025 Rallies & Real-Time Market Trend Scan - Newser
Can volume confirm reversal in GeoVax Labs Inc. Equity WarrantJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - Newser
Is GeoVax Labs Inc. a momentum stockSmart Trades with Big Payoffs - thegnnews.com
Pattern Scan Adds GeoVax Labs Inc. to WatchlistSwing Trade Plans Emphasize Risk Management - beatles.ru
GeoVax Labs Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingStrategy Builder for Growth Focused Traders - Newser
GeoVax Labs Gains Favor as HHS Terminates mRNA Vaccine Contracts - AInvest
GeoVax Advocates for MVA-Based Vaccines Following HHS mRNA Vaccine Rollback - citybuzz -
GeoVax Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen Vaccine - NewMediaWire
GeoVax Labs Earnings Call: Mixed Results and Future Prospects - TipRanks
What is GeoVax Labs Inc. Equity Warrant company’s growth strategyAccelerated financial growth - Jammu Links News
What makes GeoVax Labs Inc. Equity Warrant stock price move sharplyGet timely alerts on market movers - Jammu Links News
How does GeoVax Labs Inc. generate profit in a changing economyAchieve rapid portfolio growth with smart picks - Jammu Links News
What analysts say about GeoVax Labs Inc. stockHigh-velocity gains - Jammu Links News
What are the technical indicators suggesting about GeoVax Labs Inc.Build wealth faster with disciplined trading - Jammu Links News
What is the dividend policy of GeoVax Labs Inc. stockOverwhelming profit margins - Jammu Links News
What is the risk reward ratio of investing in GeoVax Labs Inc. Equity Warrant stockExponentially increasing returns - Jammu Links News
How volatile is GeoVax Labs Inc. Equity Warrant stock compared to the marketBuild wealth steadily with smart trading - Jammu Links News
How strong is GeoVax Labs Inc. Equity Warrant company’s balance sheetIdentify breakout stocks before they peak - Jammu Links News
Why GeoVax Labs Inc. stock attracts strong analyst attentionQuick Profit Setup with Signal Forecast - Newser
What institutional investors are buying GeoVax Labs Inc. Equity Warrant stockBuild a diversified portfolio for risk management - Jammu Links News
Is GeoVax Labs Inc. a growth stock or a value stockBuild wealth faster with disciplined trading - Jammu Links News
Is GeoVax Labs Inc. a good long term investmentFree Investment Risk Control - Jammu Links News
What drives GeoVax Labs Inc. Equity Warrant stock priceBuild wealth steadily with smart stock selection - Jammu Links News
What institutional investors are buying GeoVax Labs Inc. stockOutstanding yields - Jammu Links News
Why is GeoVax Labs Inc. Equity Warrant stock attracting strong analyst attentionAchieve rapid returns with smart investment plans - Jammu Links News
Is GeoVax Labs Inc. Equity Warrant stock overvalued or undervaluedGet alerts on top growth stocks daily - Jammu Links News
When is GeoVax Labs Inc. Equity Warrant stock expected to show significant growthPowerful market insights - Jammu Links News
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geovax Labs Inc Stock (GOVX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SPENCER JOHN N JR | Director |
Apr 10 '25 |
Buy |
0.98 |
10,000 |
9,800 |
11,402 |
Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):